The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- LivaNova
- Study ID
- NCT04753385
- Status
- Terminated
Conditions
- Treatment Resistant Depression
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The objective of this study is to collect both active and passive data using a wearable, multi-sensor device (Verily Study Watch) and phone application (Mood App) which aims to capture mental health status, in subjects participating in the RECOVER clinical trial (A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression).
Key Dates
- First listed
- Feb 15, 2021
- Start date
- Mar 23, 2021
- Status verified
- Dec 2024
- Primary completion
- Sep 6, 2024
- Completion
- Sep 6, 2024
Study Design
- Enrollment
- 138 participants (actual)
Primary Outcome Measure
Percentage of PHQ-8 tasks [ Time Frame: Through study completion; Average 2 years ]
Locations (33)
Find similar trials in Birmingham, AL
Related Studies
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionRecruiting · LivaNova · Birmingham, Alabama
- Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant DepressionRecruiting · Nader Pouratian · Dallas, Texas
- Biomarker-guided rTMS for Treatment Resistant DepressionPHASE3 · Recruiting · Weill Medical College of Cornell University · Stanford, California
- Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective ProcessingRecruiting · Baylor College of Medicine · Houston, Texas